List of SBIR/STTR awards granted to Collaborations Pharmaceuticals

List of SBIR/STTR awards granted to Collaborations Pharmaceuticals

List of SBIR/STTR awards granted to QUOIN INTERNATIONAL, INC.

List of SBIR/STTR awards granted to Sanaria Inc.

List of SBIR/STTR awards granted to Conductus

List of Trx Systems, Inc. patents

List of funding rounds for Cityscoot

where

SBIR/STTR Award Recipient

is

Collaborations Pharmaceuticals

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase I Award, August 2019	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in August, 2019 for $68,862.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	1R43AT010585-01	Phase I	68,862	August 15, 2019	sbir.gov/node/1684517
	‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in September, 2018 for $411,523.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	1R43NS107079-01	Phase I	411,523	September 15, 2018	sbir.gov/node/1567481
	‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to Collaborations Pharmaceuticals in September, 2021 for $855,127.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	2R44GM122196-04A1	Phase II	855,127	September 1, 2021	sbir.gov/node/2189561
	‌ COLLABORATIONS PHARMACEUTICALS, INC. STTR Phase II Award, September 2022	A STTR Phase II contract was awarded to Collaborations Pharmaceuticals in September, 2022 for $864,767.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	STTR	2R42GM131433-02	Phase II	864,767	September 6, 2022	sbir.gov/node/2299905
	‌ COLLABORATIONS PHARMACEUTICALS INC SBIR Phase II Award, June 2022	A SBIR Phase II contract was awarded to Collaborations Pharmaceuticals in June, 2022 for $1,499,923.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	2R44NS107079-02A1	Phase II	1,499,923	June 15, 2022	sbir.gov/node/2339233
	‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase I Award, September 2019	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in September, 2019 for $224,548.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	1R43ES031038-01	Phase I	224,548	September 1, 2019	sbir.gov/node/1684817
	‌ COLLABORATIONS PHARMACEUTICALS INC SBIR Phase II Award, August 2022	A SBIR Phase II contract was awarded to Collaborations Pharmaceuticals in August, 2022 for $855,003.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	2R44ES031038-02A1	Phase II	855,003	August 1, 2022	sbir.gov/node/2337547
	‌ COLLABORATIONS PHARMACEUTICALS INC SBIR Phase I Award, December 2021	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in December, 2021 for $256,385.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	1R43ES033855-01	Phase I	256,385	December 10, 2021	sbir.gov/node/2336481
	‌ COLLABORATIONS PHARMACEUTICALS, INC. STTR Phase I Award, February 2018	A STTR Phase I contract was awarded to Collaborations Pharmaceuticals in February, 2018 for $224,998.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	STTR	1R41AI134561-01A1	Phase I	224,998	February 7, 2018	sbir.gov/node/1566749
	‌ COLLABORATIONS PHARMACEUTICALS, INC. STTR Phase I Award, April 2019	A STTR Phase I contract was awarded to Collaborations Pharmaceuticals in April, 2019 for $210,712.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	STTR	1R41GM131433-01A1	Phase I	210,712	April 1, 2019	sbir.gov/node/1680395
	‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase II Award, August 2018	A SBIR Phase II contract was awarded to Collaborations Pharmaceuticals in August, 2018 for $1,575,776.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	2R44GM122196-02A1	Phase II	1,575,776	August 1, 2018	sbir.gov/node/1568903
	‌ COLLABORATIONS PHARMACEUTICALS INC SBIR Phase I Award, April 2022	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in April, 2022 for $256,220.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	1R43DA055419-01	Phase I	256,220	April 15, 2022	sbir.gov/node/2336635
	‌ COLLABORATIONS PHARMACEUTICALS, INC. SBIR Phase I Award, January 2017	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in January, 2017 for $149,999.0 USD from the U.S. Department of Health & Human Services.	Collaborations Pharmaceuticals			SBIR	1R43GM122196-01	Phase I	149,999	January 1, 2017	sbir.gov/node/1247023
	‌ COLLABORATIONS PHARMACEUTICALS, INC. STTR Phase I Award, August 2016	A STTR Phase I contract was awarded to Collaborations Pharmaceuticals in August, 2016 for $149,388.0 USD from the U.S. Department of Health & Human Services.	Collaborations Pharmaceuticals			STTR	1R41AI122434-01	Phase I	149,388	August 15, 2016	sbir.gov/node/1195211
	‌ COLLABORATIONS PHARMACEUTICALS INC SBIR Phase I Award, September 2023	A SBIR Phase I contract was awarded to Collaborations Pharmaceuticals in September, 2023 for $295,096.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Collaborations Pharmaceuticals		National Institutes of Health	SBIR	1R43AI174350-01A1	Phase I	295,096	September 15, 2023	sbir.gov/node/2512555

15 results

0 selected

15 results

0 selected